Results 111 to 120 of about 3,283 (198)

Dynamics of Treatment Response to Faricimab for Diabetic Macular Edema [PDF]

This study analyzes the dynamics of short-term treatment response to the first intravitreal faricimab injection in eyes with diabetic macular edema (DME). This retrospective, single-center, clinical trial was conducted at the Department of Ophthalmology,
Rejdak, M, Cozzi, M, Mariano Cozzi, Kvanta, A,, Blaser, F, Katrin Fasler, Daniel R. Muth, Muth, DR, Anders Kvanta, Zweifel, SA, Fasler, K, Sandrine Zweifel, Daniel Rudolf Muth, Magdalena Rejdak, Sandrine A. Zweifel, Frank Blaser, Muth, Daniel R., Fasler, Katrin; https://orcid.org/, Kvanta, Anders; https://orcid.org/, Rejdak, Magdalena; https://orcid.org/, Zweifel, Sandrine A; https://orcid.org/, Rejdak, Magdalena, Cozzi, Mariano, Fasler, Katrin, Kvanta, Anders, Muth, Daniel R; https://orcid.org/, Cozzi, Mariano; https://orcid.org/, Zweifel, Sandrine A., Blaser, Frank   +28 more
core   +1 more source

Exudative retinopathy from retinal vasoproliferative tumor refractory to aflibercept treated with faricimab-svoa

American Journal of Ophthalmology Case Reports
Purpose: To report a case of exudative retinopathy secondary to retinal vasoproliferative tumor (RVPT) refractory to aflibercept treated with faricimab-svoa (faricimab).
Naveen Karthik, Syeda Fatima Abid, Yuxi Zheng, Miguel Materin, Xi Chen   +4 more
doaj   +1 more source

Budget Impact of Faricimab in Neovascular Age-Related Macular Degeneration in the Netherlands: A Systematic Review and Meta-Analysis of Injection Count

Ophthalmology and Therapy
Introduction Frequent anti-vascular endothelial growth factor (anti-VEGF) injections for the treatment of neovascular age-related macular degeneration (nAMD) burden patients and healthcare systems.
Mohamed El Alili, Celine J. van de Laar, Jeroen P. F. de Greeff, Johannes G. F. Vromans, Freekje van Asten, Judith E. Bosmans   +5 more
doaj   +1 more source

Real-world treatment patterns and visual outcomes of faricimab in patients with neovascular age-related macular degeneration in the UK at 12 months: the FARWIDE-nAMD study [PDF]

Background The Faricimab Real-World Evidence (FARWIDE) studies are evaluating real-world outcomes of eyes with neovascular age-related macular degeneration (nAMD) or diabetic macular oedema (DMO) treated with faricimab in the UK. Here, we present results
de Salvo, Gabriella, Dayal, Parul, de Silva, Samantha R., Varma, Deepali, Gale, Richard P., Downey, Amanda K., Patel, Praveen J., Sivaprasad, Sobha, Peto, Tunde, Downey, Louise, Dodds, Melanie, Talks, James, Reynolds, Rhianon, James, Natalee, Pearce, Ian, Chi, Gloria C., McKibbin, Martin, Kiire, Christine A., Bailey, Clare, Peto, Tunde; id_orcid   +19 more
core   +1 more source

Intravitreal faricimab pharmacokinetics assessed by PET imaging in a neovascular Age-related Macular Degeneration rat model

International Journal of Pharmaceutics: X
Age-related Macular Degeneration (AMD) is the leading cause of blindness in the elderly, with its neovascular form characterised by abnormal vessel growth.
Xurxo García-Otero, Andrea Cuartero-Martínez, Patricia Fernández-Robredo, Soraya Groba-de Antas, Noemí Gómez-Lado, Francisco J. Otero-Espinar, María Hernández, Jaione Bezunartea, Alfredo García-Layana, Sergio Recalde, Pablo Aguiar, Anxo Fernández-Ferreiro   +11 more
doaj   +1 more source

Anatomic Outcomes With Faricimab vs. Aflibercept in the Head-to-Head Dosing Phase of the TENAYA/LUCERNE Trials in Neovascular AMD.

Ophthalmology (Rochester, Minn.)
PURPOSE To compare early anatomic outcomes following treatment with faricimab vs. aflibercept in a pooled analysis of the head-to-head dosing phase of the TENAYA/LUCERNE trials in neovascular age-related macular degeneration (nAMD).
C. M. Gemmy Cheung, Jennifer I. Lim, S. Priglinger, Giuseppe Querques, Philippe Margaron, Shriji Patel, Audrey Souverain, Jeffrey R. Willis, Ming Yang, Robyn Guymer   +9 more
semanticscholar   +1 more source

Real‐World Treatment With Faricimab Improves Anatomical Biomarkers in Patients With Diabetic Macular Edema

Introduction Diabetic macular edema (DME) is a leading cause of vision loss in people with diabetes. Treatments include the use of anti–vascular endothelial growth factor (VEGF) agents such as faricimab.
Eva Alegre-Rueda, Enrique Rodríguez-de-la-Rúa-Frach, Estanislao Gutiérrez-Sánchez, Maria Luisa Moya-Martín, Isabel Romero-Barranca   +4 more
core   +1 more source

Real-World Outcomes After Switching to Faricimab in Patients with Chronic Diabetic Macular Edema at a Tertiary Eye Center in Singapore

Ophthalmology and Therapy
Introduction To evaluate visual and anatomical outcomes after switching to faricimab in Singaporean patients with diabetic macular edema (DME) previously treated with other anti‑vascular endothelial growth factor (VEGF) agents or therapies.
Kanae Fukutsu, Rose Ann Goh, Fang Zheng, Charles Ong, Anna C. S. Tan, Gemmy C. M. Cheung, SNEC Retina Research Group, Gavin S. W. Tan   +7 more
doaj   +1 more source

Real-world six-month outcomes in patients switched to faricimab following partial response to anti-VEGF therapy for neovascular age-related macular degeneration and diabetic macular oedema

Eye
Landmark studies reported on faricimab efficacy and safety predominantly in treatment naïve patients, but outcomes following switch from other anti-VEGF therapies are lacking. We evaluated patients switched to faricimab who had previously shown a partial
Grace A. Borchert, C. Kiire, Niamh Stone, H. Akil, Theodora Gkika, M. Fischer, Kan-Min Xue, Jasmina Cehajic-Kapetanovic, Robert E. MacLaren, Peter Charbel Issa, S. M. Downes, S. D. De Silva   +11 more
semanticscholar   +1 more source

COMPARATIVE CLINICAL OUTCOMES OF FARICIMAB VERSUS AFLIBERCEPT IN DIABETIC MACULAR EDEMA: A FOCUSED REVIEW

This manuscript presents a focused narrative review with systematic literature identification of comparative evidence on faricimab versus aflibercept in adults with diabetic macular edema. The review prioritized randomized phase III evidence and selected
Karolina Klusek, Nadzieja Krasucka, Magdalena Kijowska, Michał Batory, Aleksandra Zynkowska, Maria Kiełbus, Aleksandra Magdalena Skrzyniarz, Julia Oziębło, Karol Kraska, Jakub Jakubowski, Oziębło, Julia, Kiełbus, Maria, Batory, Michał, Kijowska, Magdalena, Klusek, Karolina, Zynkowska, Aleksandra, Skrzyniarz, Aleksandra Magdalena, Jakubowski, Jakub, Krasucka, Nadzieja, Kraska, Karol   +19 more
core   +1 more source